Article

Novel One-Step Nucleic Acid Amplification (OSNA) Application in Prostate Cancer. What Can We Learn from its Usage in Other Cancer Entities? A Systematic Review

2021-09-16

Abstract excerpt

<h4>Background: </h4> Lymph node (LN) status is a key prognostic factor in the decision-making process of prostate cancer (PCa) management. Sectioning and haematoxylin and eosin (H&E) staining technique remain the gold standard for the evaluation of LN metastases despite some limitations, especially low sensitivity in detecting an accurate tumour burden within the LN, as well as a subjective and time-consuming res...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 84be56e2-8b4f-5319-88d7-a3b68ddd19a0
DOI: 10.21203/rs.3.rs-840288/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Novel One-Step Nucleic Acid Amplification (OSNA) Application in Prostate Cancer. What Can We Learn from its Usage in Other Cancer Entities? A Systematic ReviewDOI 10.21203/rs.3.rs-840288/v1Read

One-step Nucleic Acid Amplification Can Identify Sentinel Node-negative Breast Cancer Patients With Excellent PrognosisSemantic proximity Read

Unveiling Novel Double-Negative Prostate Cancer Subtypes Through Single-Cell RNA Sequencing AnalysisSemantic proximity Read

Genomic landscape alterations in primary tumor and matched lymph node metastasis in prostate cancer patientsSemantic proximity Read

Can We Predict Prostate Cancer Metastasis Based on Biomarkers? Where Are We Now?Semantic proximity Read

An 18-Gene Algorithm urine test for predicting prostate cancer metastasis and castration- resistanceSemantic proximity Read

The utility of next-generation sequencing in metastatic prostate cancer FNA biopsies.Semantic proximity Read

Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI- Driven BiomarkersSemantic proximity Read

SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure: BOP).Semantic proximity Read

Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53.Semantic proximity Read

A Novel Gene Signature for Molecular Diagnosis of Human Prostate Cancer by RT-qPCRSemantic proximity Read

Unveiling potential: urinary exosomal mRNAs as non-invasive biomarkers for early prostate cancer diagnosisSemantic proximity Read

SPAG1 Expression as a Candidate Predictor of Pathological Lymph Node Metastasis in Prostate Cancer: A Transcriptomic Analysis of The Cancer Genome Atlas Prostate Adenocarcinoma CohortSemantic proximity Read